INTERCURE LTD (INCR) Stock Price & Overview
NASDAQ:INCR • IL0011063760
The current stock price of INCR is 0.8504 USD. Today INCR is up by 0.05%. In the past month the price decreased by -4.9%. In the past year, price decreased by -47.18%.
INCR Key Statistics
- Market Cap
- 46.5M
- P/E
- N/A
- Fwd P/E
- 4.42
- EPS (TTM)
- -0.48
- Dividend Yield
- N/A
INCR Stock Performance
INCR Stock Chart
INCR Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to INCR. When comparing the yearly performance of all stocks, INCR is a bad performer in the overall market: 92.98% of all stocks are doing better.
INCR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to INCR. INCR has a bad profitability rating. Also its financial health evaluation is rather negative.
INCR Earnings
INCR Forecast & Estimates
For the next year, analysts expect an EPS growth of 1550% and a revenue growth 39.3% for INCR
INCR Groups
Sector & Classification
INCR Financial Highlights
Over the last trailing twelve months INCR reported a non-GAAP Earnings per Share(EPS) of -0.48. The EPS decreased by -8.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.62% | ||
| ROE | -14.9% | ||
| Debt/Equity | 0.23 |
INCR Ownership
INCR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 29.29 | 948.755B | ||
| JNJ | JOHNSON & JOHNSON | 20.57 | 591.001B | ||
| MRK | MERCK & CO. INC. | 21.45 | 298.537B | ||
| PFE | PFIZER INC | 8.86 | 151.354B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.98 | 126.888B | ||
| ZTS | ZOETIS INC | 17.8 | 55.509B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.81 | 27.378B | ||
| VTRS | VIATRIS INC | 5.79 | 16.937B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.74 | 12.151B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.393B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.67B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.517B | ||
| GPCR | STRUCTURE THERAPEUTICS INC | N/A | 4.459B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About INCR
Company Profile
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Company Info
INTERCURE LTD
Medinat HaYehudim 85
Herzliya 27604 IL
CEO: Alistair Macdonald
Employees: 320
Phone: 972774605012
INTERCURE LTD / INCR FAQ
What does INTERCURE LTD do?
InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Can you provide the latest stock price for INTERCURE LTD?
The current stock price of INCR is 0.8504 USD. The price increased by 0.05% in the last trading session.
What is the dividend status of INTERCURE LTD?
INCR does not pay a dividend.
What is the ChartMill rating of INTERCURE LTD stock?
INCR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists INCR stock?
INCR stock is listed on the Nasdaq exchange.
Is INTERCURE LTD (INCR) expected to grow?
The Revenue of INTERCURE LTD (INCR) is expected to grow by 39.3% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of INCR stock?
INTERCURE LTD (INCR) has a market capitalization of 46.50M USD. This makes INCR a Nano Cap stock.